Nemaura Medical Inc. (NMRD) Financial Statements (2024 and earlier)
Company Profile
Business Address |
57 WEST 57TH STREET MANHATTAN, NY 10019 |
State of Incorp. | |
Fiscal Year End | March 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2023 Q2 | 6/30/2023 Q1 | 3/31/2023 Q4 | 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 4,010 | 10,105 | 7,341 | 10,110 | 14,752 | 17,749 | |||
Cash and cash equivalents | 4,010 | 10,105 | 7,341 | 10,110 | 14,752 | 17,749 | |||
Receivables | 254 | 410 | 25 | 218 | 101 | ||||
Inventory, net of allowances, customer advances and progress billings | 2,351 | 1,755 | 2,352 | 1,910 | 1,625 | 1,488 | |||
Inventory | 2,351 | 1,755 | 2,352 | 1,910 | 1,625 | 1,488 | |||
Prepaid expense | 474 | ||||||||
Advance royalties | 1,000 | ||||||||
Other undisclosed current assets | 858 | 268 | 1,217 | 1,934 | 1,105 | 276 | |||
Total current assets: | 7,473 | 13,537 | 10,936 | 13,954 | 17,700 | 20,088 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 629 | 642 | |||||||
Intangible assets, net (including goodwill) | 348 | 384 | |||||||
Intangible assets, net (excluding goodwill) | 348 | 384 | |||||||
Other noncurrent assets | 2,026 | 1,949 | 2,015 | 2,013 | |||||
Total noncurrent assets: | 977 | 1,026 | 2,026 | 1,949 | 2,015 | 2,013 | |||
TOTAL ASSETS: | 8,450 | 14,563 | 12,962 | 15,903 | 19,715 | 22,102 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 257 | 327 | 171 | 301 | 93 | 136 | |||
Accounts payable | 257 | 327 | 171 | 301 | 93 | 136 | |||
Deferred revenue | 127 | 124 | 70 | 71 | 178 | 259 | |||
Debt | 16,968 | 16,943 | 11,513 | 17,197 | 15,870 | 19,189 | |||
Due to related parties | ✕ | ✕ | ✕ | 122 | |||||
Other liabilities | 391 | 398 | 438 | 999 | |||||
Other undisclosed current liabilities | 4,303 | 4,875 | 1,076 | 2,066 | 1,280 | ||||
Total current liabilities: | 21,654 | 22,268 | 13,220 | 20,155 | 17,858 | 20,583 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 119 | 3,088 | 8,558 | 3,491 | 4,700 | ||||
Long-term debt, excluding current maturities | 119 | 3,088 | 8,558 | 3,491 | 4,700 | ||||
Other undisclosed noncurrent liabilities | 1,054 | 1,022 | 1,043 | 956 | 1,025 | 1,053 | |||
Total noncurrent liabilities: | 1,173 | 4,109 | 9,600 | 4,447 | 5,725 | 1,053 | |||
Total liabilities: | 22,828 | 26,377 | 22,820 | 24,602 | 23,583 | 21,636 | |||
Equity | |||||||||
Equity, attributable to parent | (14,378) | (11,814) | (9,859) | (8,699) | (3,868) | 466 | |||
Common stock | 29 | 29 | 24 | 24 | 24 | 24 | |||
Additional paid in capital | 40,991 | 40,991 | 38,296 | 38,296 | 38,296 | 38,296 | |||
Accumulated other comprehensive loss | (920) | (959) | (987) | (1,543) | (567) | (122) | |||
Accumulated deficit | (54,478) | (51,875) | (47,192) | (45,476) | (41,620) | (37,731) | |||
Total equity: | (14,378) | (11,814) | (9,859) | (8,699) | (3,868) | 466 | |||
TOTAL LIABILITIES AND EQUITY: | 8,450 | 14,563 | 12,962 | 15,903 | 19,715 | 22,102 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2023 Q2 | 6/30/2023 Q1 | 3/31/2023 Q4 | 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 3 | 74 | 504 | |||||
Cost of revenue (Cost of Goods and Services Sold) | (0) | (3) | (72) | |||||
Other undisclosed gross profit | (1,478) | |||||||
Gross profit: | (1,478) | 0 | 2 | |||||
Operating expenses | (2,058) | (2,809) | (633) | (2,240) | (2,437) | (4,523) | ||
Other undisclosed operating income | 224 | 160 | ||||||
Operating loss: | (1,834) | (4,287) | (633) | (2,238) | (2,437) | (4,363) | ||
Loss from continuing operations before equity method investments, income taxes: | (1,834) | (4,287) | (633) | (2,238) | (2,437) | (4,363) | ||
Other undisclosed loss from continuing operations before income taxes | (4,549) | (5,746) | ||||||
Loss from continuing operations before income taxes: | (1,834) | (8,835) | (633) | (2,238) | (2,437) | (10,109) | ||
Other undisclosed income from continuing operations | 38 | 350 | ||||||
Loss from continuing operations: | (1,834) | (8,798) | (633) | (2,238) | (2,437) | (9,759) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | (9,759) | |
Other undisclosed net loss | (769) | (38) | (1,617) | |||||
Net loss: | (2,603) | (8,835) | (633) | (3,856) | (2,437) | (9,759) | ||
Other undisclosed net income (loss) attributable to parent | 4,152 | (1,083) | (1,452) | |||||
Net loss available to common stockholders, diluted: | (2,603) | (4,683) | (1,716) | (3,856) | (3,889) | (9,759) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2023 Q2 | 6/30/2023 Q1 | 3/31/2023 Q4 | 12/31/2022 Q3 | 9/30/2022 Q2 | 6/30/2022 Q1 | 3/31/2022 Q4 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (2,603) | (8,835) | (633) | (3,856) | (2,437) | (9,759) | ||
Other undisclosed comprehensive loss | (440) | |||||||
Comprehensive loss: | (2,603) | (8,835) | (633) | (3,856) | (2,437) | (10,199) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 40 | 4,180 | (527) | (975) | (1,897) | (174) | ||
Comprehensive loss, net of tax, attributable to parent: | (2,564) | (4,655) | (1,160) | (4,831) | (4,334) | (10,373) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.